Flora Coulon

Title: Flora Coulon: Innovator in Recombinant Monovalent Antibodies

Introduction

Flora Coulon is a notable inventor based in Saint Georges de Montaigu, France. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant monovalent antibodies. With a total of two patents to her name, her work has the potential to impact therapeutic applications significantly.

Latest Patents

Flora's latest patents focus on recombinant monovalent antibodies. These antibodies are heterodimers consisting of a first protein chain that includes the variable domain of the heavy chain of an antibody of interest, along with the CH2 and CH3 domains of an IgG immunoglobulin. The second protein chain comprises the variable domain of the light chain of the same immunoglobulin and the CH2 and CH3 domains of the IgG immunoglobulin. These innovative antibodies can be utilized as therapeutic agents, particularly in scenarios where monovalent binding to a ligand, such as a cellular receptor, is essential.

Career Highlights

Throughout her career, Flora has worked with prominent organizations, including Ose Immunotherapeutics and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to refine her expertise in antibody development and therapeutic applications.

Collaborations

Flora has collaborated with notable colleagues, including Bernard Vanhove and Caroline Mary. These partnerships have contributed to her research and the advancement of her innovative projects.

Conclusion

Flora Coulon is a pioneering inventor whose work in recombinant monovalent antibodies holds promise for future therapeutic applications. Her contributions to biotechnology continue to inspire advancements in the field.